FDA approves ReNeuron’s cryopreserved formulation of retinal stem cell therapy candidate – Healio
|
FDA approves ReNeuron's cryopreserved formulation of retinal stem cell therapy candidate
Healio “We are delighted that the FDA has approved the use of the cryopreserved formulation of our hRPC retinal cell therapy candidate in our ongoing clinical development programs,” Olav Hellebø, CEO of ReNeuron, said in the release. “This is a further … |
